SP - Special Notices

ANNOUNCEMENTS - November 8, 2001

• BILLING ADDRESS CHANGE FOR HEADQUARTERS DOE CONTRACTORS/RECIPIENT
  U.S. Department Of Energy, Document Control Specialist, Washington, DC 20585
• MISSION SOLUTION ANALYSIS KICK-OFF MEETING TO COMPLETE MID-FAR-TERM CONCEPTS IN DETAIL TO SATISFY DEFICIENCIES IDENTIFIED BY US AIR FORCE SPACE COMMAND (AFSPC)
  Department of the Air Force, Air Force Space Command, SMC -- Space and Missiles System Center, 2420 Vela Way, Suite 1467, El Segundo, CA, 90245-4659
• THE SBIR BIDDER'S COURSE AND WORKSHOP
  George Mason University, Procurement Technical Assistance Program, 4031 University Dr. Enterprise Center, Fairfax, VA 22030-4444
• BILLING ADDRESS CHANGE FOR HEADQUARTERS DOE CONTRACTORS/RECIPIENT
  U.S. Department Of Energy, Document Control Specialist, Washington, DC 20585
• PROPOSED ADDITIONS OF COMMODITIES TO THE COMMITTEE'S PROCUREMENT LIST
  Committee for Purchase from People Who are Blind or Severly Disabled, 1421 Jefferson Davis Hwy., Room 10800, Arlington, VA 22202-3259
• REQUEST FOR QUOTATION -- STANDING PRICE QUOTE -- NATIONAL STOCK NUMBER- 8030-01-389-1408
  General Services Administration, Federal Supply Service (FSS), GSA Hardware SuperStore (6FE), 1500 East Bannister Road, Kansas City, MO, 64131
• EVALUATION OF VASOSTATIN, AN INHIBITOR OF ANGIOGENESIS, AS A POTENTIAL CANCER THERAPEUTIC.
  NIH/TDCB, 6120 Executive Blvd., Suite 450, Rockville, MD 20852
• BUSINESS OPPORTUNITIES FOR PHD NSWC, ALL SITES
  Port Hueneme Div. Code 1E00, NavSurfWarCen, 4363 Missile Way, Port Hueneme, CA 93043-4307
• SCIENTIFIC AND COMMERCIAL DEVELOPMENT OF A NOVEL DRUG TARGETING MELANIN PRODUCING CELLS
  NIH/TDCB, 6120 Executive Blvd., Suite 450, Rockville, MD 20852
• BOARD CERTIFIED PHYSICIAN AT THE ROSEBUD PHS, IHS HOSPITAL, ROSEBUD, SD 57570
  Department of Health and Human Services, Indian Health Service, Aberdeen Area Office, Federal Building, 115 4th Avenue SE, Aberdeen, SD, 57401
• SCIENTIFIC AND COMMERCIAL DEVELOPMENT OF OLIGONUCLEOTIDES TO PROTECT NORMAL CELLS FROM TOXICITY SECONDARY TO CHEMOTHERAPY. THE OLIGONUCLEOTIDES WOULD BE USED TO TREAT SUCH CONDITIONS AS ALOPECIA (HAIR LOSS) AND MUCOSITIS.
  NIH/TDCB, 6120 Executive Blvd., Suite 450, Rockville, MD 20852
• PRODUCTION OF CLINICAL GRADE DNA VECTORS EXPRESSING CO-STIMULATORY MOLECULES FOR ENHANCING THE EFFECT OF SPECIFIC ANTIGEN-PEPTIDE VACCINATION IN CANCER PATIENTS.
  NIH/TDCB, 6120 Executive Blvd., Suite 450, Rockville, MD 20852